UA117525C2 - METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY - Google Patents

METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY

Info

Publication number
UA117525C2
UA117525C2 UAA201611246A UAA201611246A UA117525C2 UA 117525 C2 UA117525 C2 UA 117525C2 UA A201611246 A UAA201611246 A UA A201611246A UA A201611246 A UAA201611246 A UA A201611246A UA 117525 C2 UA117525 C2 UA 117525C2
Authority
UA
Ukraine
Prior art keywords
development
preeclampy
diagnostics
heavy
tgf
Prior art date
Application number
UAA201611246A
Other languages
Ukrainian (uk)
Inventor
Микола Олександрович Щербина
Оксана Петрівна Ліпко
Ірина Миколаївна Щербина
Олександра Олексіївна Диннік
Original Assignee
Харківський Національний Медичний Університет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харківський Національний Медичний Університет filed Critical Харківський Національний Медичний Університет
Priority to UAA201611246A priority Critical patent/UA117525C2/en
Publication of UA117525C2 publication Critical patent/UA117525C2/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Винахід належить до способу діагностики розвитку тяжкої прееклампсії, який включає визначення плацентарних факторів ризику розвитку цього захворювання, де при діагностуванні de novo артеріальної гіпертензії визначають рівень трансформуючого фактора росту (ТФР) і при підвищенні рівня ТФР до 14637±529 пг/мл діагностують розвиток тяжкої прееклампсії.The invention relates to a method for diagnosing the development of severe preeclampsia, which includes the determination of placental risk factors for the disease, where the diagnosis of de novo arterial hypertension determine the level of transforming growth factor (TGF) and when increasing the level of TGF to 14637 ± 529 pg / ml diagnose the development of .

UAA201611246A 2016-11-07 2016-11-07 METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY UA117525C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201611246A UA117525C2 (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201611246A UA117525C2 (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY

Publications (1)

Publication Number Publication Date
UA117525C2 true UA117525C2 (en) 2018-08-10

Family

ID=63080769

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201611246A UA117525C2 (en) 2016-11-07 2016-11-07 METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY

Country Status (1)

Country Link
UA (1) UA117525C2 (en)

Similar Documents

Publication Publication Date Title
MX2018012580A (en) Methods and kits for the diagnosis and risk stratification of patients with ischemia.
DE602006011896D1 (en) DIAGNOSTIC PROCEDURE FOR DISEASES ASSOCIATED WITH BRAIN DAMAGE
WO2018038352A3 (en) Autoantibody biomarker for diagnosing dementia and method for diagnosing dementia by using same
EP4299586A3 (en) Methods and compositions for the detection and diagnosis of renal disease and periodontal disease
MX2018006189A (en) Lactoferrin for use in the diagnosis or prognosis of alzheimer's disease, or in the diagnosis of parkinson's disease.
MX2019012439A (en) Diagnostic tool to determine podocyte foot process effacement.
WO2017029401A8 (en) Means and methods for diagnosing cardiac disease in a subject
UA117525C2 (en) METHOD OF DIAGNOSTICS OF THE DEVELOPMENT OF HEAVY PREECLAMPY
MY179665A (en) In vitro diagnostic method for alzhemer's disease based on the albumin redox level in the cerebrospinal fluid
EP4368993A3 (en) Gingivitis diagnostic methods, uses and kits
RU2016117069A (en) A method for diagnosing the severity of hyperandrogenism
UA97389U (en) Method for early diagnostics of primary disorders of renal function in patients with newly diagnosed pulmonary tuberculosis
UA108301U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA108369U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
FR3091351B1 (en) FABRY'S DISEASE BIOMARKER
RU2019133312A (en) Method for early preclinical diagnosis of Parkinson's disease by the concentration of catecholamines in the patient's lacrimal fluid
CY1124477T1 (en) BIO-SENSOR AND METHOD FOR THE EARLY DIAGNOSIS OF GLAUCOMA
UA110748U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA110076U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA110957U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA108294U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
WO2019234677A3 (en) Biomarkers for non-invasive early diagnosis of infectious diseases
UA110195U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA108353U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT
UA109630U (en) METHOD OF DIAGNOSTICS OF OSTEOPOROSIS DEVELOPMENT